Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Pharma
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Three pharma companies plan manufacturing expansions. Kyowa Kirin's gene therapy set a new pricing record. BeiGene won an FDA nod for its PD-1 drug.
Angus Liu
Mar 22, 2024 8:45am
Takeda's Iclusig wins first-line FDA nod to treat Ph+ALL
Mar 19, 2024 3:22pm
BIO-WuXi, Takeda, FDA-Carvykti—Fierce Pharma Asia
Mar 15, 2024 10:15am
Takeda to lay off 190 Austrian workers after gene therapy pivot
Mar 13, 2024 10:15am
BeiGene, BMS, AZ-FibroGen and more—Fierce Pharma Asia
Mar 1, 2024 8:55am
Takeda taps India's Biological E to ramp up Qdenga manufacturing
Feb 27, 2024 11:33am